Home Finance Genmab stock surges 9% following positive phase 3 ovarian cancer trial results
Finance

Genmab stock surges 9% following positive phase 3 ovarian cancer trial results

Share
Genmab stock surges 9% following positive phase 3 ovarian cancer trial results
Share


Genmab stock surges 9% following positive phase 3 ovarian cancer trial results

Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *